Small cell lung cancer
Small cell lung cancer (SCLC) accounts for about 20% of lung cancer. It is highly malignant, has a short doubling time, early and extensive metastasis, is sensitive to chemotherapy and radiotherapy, and has a high initial remission rate. However, it is very prone to secondary drug resistance and relapse. Treatment is mainly systemic chemotherapy.
-
Site of disease:
lung -
Infectious :
Not contagious -
Frequent population:
Middle-aged smokers are more likely to -
Related symptoms:
Fatigue cough shortness of breath weight loss
Related Drugs
Etoposide
Indication: Mainly for small cell lung cancer, the effective rate increased from 40% to 85%, and the complete remission rate was 14% to 34%. For small cell lung cancer, oral administration is more effective than intravenous injection.
Manufacturer:
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Etoposide
Indication: Mainly for small cell lung cancer, the effective rate increased from 40% to 85%, and the complete remission rate was 14% to 34%. For small cell lung cancer, oral administration is more effective than intravenous injection.
Manufacturer:
Wichita, Its Group of Pharmaceutical Co., Ltd.
Etoposide
Indication: Mainly for small cell lung cancer, the effective rate increased from 40% to 85%, and the complete remission rate was 14% to 34%. For small cell lung cancer, oral administration is more effective than intravenous injection.
Manufacturer:
Wichita, Its Group of Pharmaceutical Co., Ltd.
Docetaxel
Indication: It is mainly used to treat advanced breast cancer, ovarian cancer, non-small cell lung cancer, head and neck cancer, and small cell lung cancer; it also has certain effects on gastric cancer, pancreatic cancer, melanoma, etc.
Manufacturer:
Qilu Pharmaceutical Co., Ltd.
Docetaxel
Indication: It is mainly used to treat advanced breast cancer, ovarian cancer, non-small cell lung cancer, head and neck cancer, and small cell lung cancer; it also has certain effects on gastric cancer, pancreatic cancer, melanoma, etc.
Manufacturer:
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Docetaxel
Indication: It is mainly used to treat advanced breast cancer, ovarian cancer, non-small cell lung cancer, head and neck cancer, and small cell lung cancer; it also has certain effects on gastric cancer, pancreatic cancer, melanoma, etc.
Manufacturer:
Zhejiang Hisun Pharmaceutical Co., Ltd.
Docetaxel
Indication: It is mainly used to treat advanced breast cancer, ovarian cancer, non-small cell lung cancer, head and neck cancer, and small cell lung cancer; it also has certain effects on gastric cancer, pancreatic cancer, melanoma, etc.
Docetaxel
Indication: It is mainly used to treat advanced breast cancer, ovarian cancer, non-small cell lung cancer, head and neck cancer, and small cell lung cancer; it also has certain effects on gastric cancer, pancreatic cancer, melanoma, etc.
Docetaxel
Indication: It is mainly used to treat advanced breast cancer, ovarian cancer, non-small cell lung cancer, head and neck cancer, and small cell lung cancer; it also has certain effects on gastric cancer, pancreatic cancer, melanoma, etc.
Carboplatin
Indication: It is mainly used for solid tumors such as small cell lung cancer, ovarian cancer, testicular tumors, head and neck cancer and malignant lymphoma, etc. It has good curative effect. It can also be used for other tumors such as cervical cancer, bladder cancer and non-small cell lung cancer.
Manufacturer:
Kunming Guiyan Pharmaceutical Co., Ltd.
Related Ingredients